share_log

Where Enovix Stands With Analysts

Where Enovix Stands With Analysts

Enovix在分析师中的地位
Benzinga ·  08/05 17:00
Throughout the last three months, 7 analysts have evaluated Enovix (NASDAQ:ENVX), offering a diverse set of opinions from bullish to bearish.
在过去的三个月里,有7位分析师对Enovix (纳斯达克: ENVX)进行了评估,提供了从看好到看淡的不同观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估,下表展示了过去30天内不断变化的情绪,并将其与之前的几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $20.71, a high estimate of $30.00, and a low estimate of $14.00. Witnessing a positive shift, the current average has risen by 9.98% from the previous average price target of $18.83.
通过分析师评估的12个月目标价格,可以得出更多见解,平均目标价格为20.71美元,最高预估为30.00美元,最低预估为14.00美元。当前的平均目标价格已经上升了9.98%,从之前的平均目标价格18.83美元。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查:一项详尽的研究
The standing of Enovix among financial experts becomes clear with...
通过对最近分析师行动...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发